FREE FOR MEMBERS!

Description: Hemophilia is a bleeding disorder caused by insufficient clotting factor in the blood. The level of severity depends on the amount of clotting factor missing. People with hemophilia often experience prolonged bleeding and for those with severe hemophilia, this can lead to permanent joint damage and life-threatening hemorrhages. Therefore, timely diagnosis and effective treatment are crucial.

The standard treatment for people with hemophilia involves management of acute bleeding and prophylaxis, the regular administration of clotting factor concentrates, to prevent bleeds. New and emerging therapies such as monoclonal antibodies and gene therapy are giving hope to those living with hemophilia.

Date: May 15, 2024

Time: 12pm – 1pm (ET)

At the end of this session, you will be able to:

• Describe the types and symptoms of hemophilia
• Outline the diagnosis and common treatments for hemophilia
• Discuss emerging therapies and implications for the lab of tomorrow

Speaker: Alysa Rossman, BSc

Alysa Rossman has a BSc in Microbiology and Immunology from Dalhousie University, Halifax, NS with a focus on cardiac research. As a key member of the Precision BioLogic team, she has five years of industry experience consulting with routine and specialty coagulation labs across North America. Alysa is passionate about educating herself and her customers and actively follows advancements in the field of hemostasis, and coagulation in particular. With a secret love of public speaking, Alysa is able to deliver scientific content in a manner that is both informative and memorable.

PEP hours: 1.0

CPS credits: 0

*Note: PEP hours and/or CPS credits will only be awarded upon successful completion of the quiz.